Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells
STAR Protocols · 2025
DOI: 10.1016/j.xpro.2024.103592 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift STAR Protocols, 2025. Verfasst von Sherry Li Zheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Pluripotent Stem Cells, Homeodomain Proteins, Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) generate blood and immune cells. Here, we present a protocol to differentiate human pluripotent stem cells (hPSCs) into hematopoietic progenitors that express the signature HSC transcription factors HLF, HOXA5, HOXA7, HOXA9, and HOXA10. hPSCs are dissociated, seeded, and then sequentially differentiated into posterior primitive streak, lateral mesoderm, artery endothelium, hemogenic endothelium, and hematopoietic progenitors through the sequential addition of defined, serum-free media. This 10-day protocol enables the manufacturing of blood and immune cells in monolayer cultures. For complete details on the use and execution of this protocol, please refer to Fowler and Zheng et al.1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA. Electronic address: slzheng@stanf…
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA.
- Stem Cell Program, Boston Children's Hospital, Boston, MA 02115, USA; Division of Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA; Department of Biological Chemist…
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Urology, Stanford University, Stanford, CA 94305, USA.
- Institute for Stem Cell Biology & Regenerative Medicine, Stanford University, Stanford, CA 94305, USA; Department of Developmental Biology, Stanford University, Stanford, CA 94305, USA. Electronic address: kyleloh@stanf…
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NIGMS NIH HHS
- Barry Goldwater Scholarship and Excellence in Education Foundation
- David and Lucile Packard Foundation
- Human Frontier Science Program
- Ludwig Institute for Cancer Research Ltd
Zitieren
APA
Zheng, S. L., Fowler, J. L., Chen, J. Y., Li, C., Lin, E., Nguyen, A. T., Chen, A., Daley, G. Q., Ang, L. T., & Loh, K. M. (2025). Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells. STAR Protocols. https://doi.org/10.1016/j.xpro.2024.103592
Vancouver
Zheng SL, Fowler JL, Chen JY, Li C, Lin E, Nguyen AT, et al. Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells. STAR Protocols. 2025. doi:10.1016/j.xpro.2024.103592
BibTeX
@article{Zheng2025,
author = {Zheng, Sherry Li and Fowler, Jonas L and Chen, Julie Y and Li, Christopher and Lin, Elaine and Nguyen, Alana T and Chen, Angela and Daley, George Q and Ang, Lay Teng and Loh, Kyle M},
title = {Protocol for the generation of HLF+ HOXA+ human hematopoietic progenitor cells from pluripotent stem cells},
journal = {STAR Protocols},
year = {2025},
doi = {10.1016/j.xpro.2024.103592}
}
EUVIMED